Quick Takeaways
- Anna Moore has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $791,920.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Anna Moore
- Location
- Boston, MA
- Summary
- The estimated net worth of Anna Moore is at least $791,920 dollars as of 08 Jul 2021. Anna Moore is the 10%+ Owner of Transcode Therapeutics, Inc. and owns shares of Transcode Therapeutics, Inc. (RNAZ) stock worth about $791.9K.
- Signature
- /s/ Thomas A. Fitzgerald, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Anna Moore and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Transcode Therapeutics, Inc. ($791,920).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Anna Moore
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RNAZ | Transcode Therapeutics, Inc. | 10%+ Owner | $791,920 | 08 Jul 2021 |
Insider Transactions Reported by Anna Moore:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.